Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPX
3251
DELISTED
Marine Products Corp
MPX
| $263K | ﹤0.01% |
22,752
+5,165
| +29% | +$62.4K |
|
3252
Telesat
TSAT
$611M
| $263K | ﹤0.01% |
15,910
-11,894
| -43% | -$265K |
|
|
QTNT
3253
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $263K | ﹤0.01% |
5,468
+463
| +9% | +$27.7K |
|
|
GBL
3254
DELISTED
GAMCO Investors, Inc.
GBL
| $262K | ﹤0.01% |
11,811
-1,320
| -10% | -$29.3K |
|
|
FLNT
3255
Fluent
FLNT
$104M
| $260K | ﹤0.01% |
20,763
+5,971
| +40% | +$60.9K |
|
3256
Dianthus Therapeutics
DNTH
$5.8B
| $259K | ﹤0.01% |
5,572
+381
| +7% | +$20.8K |
|
3257
PAVmed
PAVM
$39.4M
| $258K | ﹤0.01% |
434
+24
| +6% | +$17.8K |
|
3258
TSMC
TSM
$2.11T
| $258K | ﹤0.01% |
2,473
-474
| -16% | -$55.4K |
|
|
ADVM
3259
DELISTED
Adverum Biotechnologies
ADVM
| $257K | ﹤0.01% |
19,589
-2,025
| -9% | -$29.6K |
|
3260
Agnico Eagle Mines
AEM
$74.6B
| $257K | ﹤0.01% |
+4,194
| New | +$227K |
|
3261
Celcuity
CELC
$4.28B
| $256K | ﹤0.01% |
27,276
+1,989
| +8% | +$20.7K |
|
3262
Cardiff Oncology
CRDF
$72.7M
| $256K | ﹤0.01% |
103,143
+5,380
| +6% | +$19K |
|
|
CDAK
3263
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $256K | ﹤0.01% |
40,827
| – | – |
|
3264
Sprinklr
CXM
$1.53B
| $255K | ﹤0.01% |
+21,387
| New | +$258K |
|
|
TAST
3265
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $255K | ﹤0.01% |
112,699
+41,800
| +59% | +$107K |
|
|
SMED
3266
DELISTED
Sharps Compliance Corp
SMED
| $255K | ﹤0.01% |
43,201
-1,255
| -3% | -$7.88K |
|
3267
Alpha Teknova
TKNO
$284M
| $254K | ﹤0.01% |
18,357
| – | – |
|
|
LOTZ
3268
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $253K | ﹤0.01% |
183,996
| – | – |
|
3269
iBio
IBIO
$70.5M
| $252K | ﹤0.01% |
1,172
+108
| +10% | +$22.6K |
|
3270
Acumen Pharmaceuticals
ABOS
$157M
| $248K | ﹤0.01% |
63,251
+39,214
| +163% | +$213K |
|
3271
Spyre Therapeutics
SYRE
$8.24B
| $246K | ﹤0.01% |
4,272
+293
| +7% | +$24.6K |
|
|
AC
3272
DELISTED
Associated Capital Group
AC
| $242K | ﹤0.01% |
+5,772
| New | +$239K |
|
3273
Rapid Micro Biosystems
RPID
$106M
| $241K | ﹤0.01% |
35,478
+14,059
| +66% | +$104K |
|
3274
Tecnoglass Holdings Inc.
TGLS
$2.07B
| $240K | ﹤0.01% |
9,485
| – | – |
|
|
IMDX
3275
Insight Molecular Diagnostics
IMDX
$162M
| $239K | ﹤0.01% |
8,009
| – | – |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.